This article was originally published on PharmaTimes http://www.pharmatimes.com/news/mallinckrodt_to_split_business_1272150

UK-based specialty pharma group Mallinckrodt has unveiled plans to spin-off its specialty generics and active pharmaceutical ingredients business into a new company

Related Posts